Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions

Biomarker roadmap and strategy

Develop a biomarker roadmap for a success in developing targeted therapies

Immuno-oncology drug developers are seeking to use biomarkers for targeted therapies, in order to help deliver treatments to patients more cost-effectively. Having a comprehensive biomarker strategy will make a big impact on your program, and a biomarker-driven approach to developing targeted therapies enables risk mitigation throughout the drug development and commercialization process.

Download our biomarker roadmap factsheet to determine the steps to a successful biomarker strategy that will drive your precision medicines and biomarkers across the drug development continuum to optimize outcomes.

You’ll learn:
  • How to develop a biomarker strategy for the product’s development cycle.
  • When and how to select the right biomarker.
  • Key factors to ensure successful biomarker roadmap development.
At Q2 Solutions, we are committed to providing solutions for the discovery and development of innovative medicines and technologies that transform how people live with and survive cancer. We understand the challenges in developing biomarkers that best support your objectives. Our scientific experts can provide you with laboratory services for the right approach for successful oncology trials, from early clinical development through pre-launch and commercialization.

Contact us to learn more about Q2 Solutions’ expertise in biomarker strategy and technologies to optimize patient outcomes.

Related Services:
Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Genomic Based Solutions for Your Immuno-oncology Drug Development Needs

Genomics-based biomarker approach

Clinical Trials Laboratories in the Immuno-Oncology Setting

Increased demands lead to increased opportunities

Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Genomic Know-How® for your drug development needs

Learn more about our genomic services

Personalizing oncology with genomics

Next-generation sequencing will transform oncology clinical trials and treatments for cancer

Read More